Effects of anticonvulsant drugs on brain amino acid metabolism.
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000596:Amino Acids / Q000378:metabolism*; D000600:Amino Acids, Dicarboxylic / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001224:Aspartic Acid / Q000378:metabolism; D001569:Benzodiazepines / Q000494:pharmacology; D001696:Biomechanical Phenomena; D001921:Brain / Q000378:metabolism*; D004789:Enzyme Activation / Q000187:drug effects; D005971:Glutamates / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D006801:Humans; D009433:Neural Inhibition; D010634:Phenobarbital / Q000494:pharmacology; D013569:Synapses / Q000187:drug effects; D014635:Valproic Acid / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000596:Amino Acids; D000600:Amino Acids, Dicarboxylic; D000927:Anticonvulsants; D005971:Glutamates; D001569:Benzodiazepines; D001224:Aspartic Acid; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D000612:4-Aminobutyrate Transaminase; D005998:Glycine; D010634:Phenobarbital